TrialClinical cancer research : an official journal of the American Association for Cancer Research2025

PSMA+ Extracellular Vesicles Are a Biomarker for SABR in Oligorecurrent Prostate Cancer: Analysis from the STOMP-like and ORIOLE Trial Cohorts.

Jack R Andrews et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.